Clinical Trial NCT04469465

Trial

Alexion – ALXN2040-PNH-301 ALPHA

Clinical trial ID

NCT04469465

Drug name

ALXN2040 D2a8n)icopan

Company:

Alexion

Drug trade name

Voydeya®

Phase of study

3

Current status

Active, not recruiting

Start

12/2020

Substance

Low molecular compound

Research question

Add-on therapy to eculizumab or ravulizumab, ALXN2040vs placebo

Delivery method of drug

Oral

Frequency

3 x daily

Clinical trial locations

Brazil Canada Czechia France Germany Greece Israel Italy Japan Malaysia Netherlands Poland South Korea Spain Taiwan Thailand UK USA